Envoy Medical Announces Reverse Stock SplitNewsfile Corp · 3 days ago
Envoy Medical Hits Six-Month Milestone, Marks Halfway Point in Final Stage of Data Collection, and Highlights Differentiated Device DesignNewsfile Corp · 5 days ago
Envoy Medical Submits Second Module of Modular Premarket Approval Application to FDA for Breakthrough Designated Acclaim(R) Cochlear ImplantNewsfile Corp · Oct 12, 2026
Envoy Medical Announces New Patents, Further Expanding Global Patent PortfolioNewsfile Corp · Sep 22, 2026
Envoy Medical to Present at the H.C. Wainwright 28th Annual Global Investment Conference on September 14th-16thNewsfile Corp · Sep 2, 2026
Envoy Medical (NASDAQ:COCH) vs. American Bio Medica (OTCMKTS:ABMC) Critical ReviewDefense World · Aug 21, 2026Envoy Medical, Inc. is a healthcare company dedicated to developing innovative medical technologies that address the full spectrum of hearing loss. Its diverse product portfolio includes conventional hearing aids, Esteem middle ear implants, bone conduction devices, and Acclaim cochlear implants. Established in 1995, the company originally operated as St.
| Date | Est. | Actual | |
|---|---|---|---|
| Aug 10, 2026 | -$0.08 | -$0.07 | Beat |
| May 11, 2026 | -$0.14 | -$0.11 | Beat |
| Mar 23, 2026 | -$0.24 | -$0.26 | Miss |
| Nov 10, 2025 | -$0.27 | -$0.35 | Miss |
| Jul 31, 2025 | -$0.29 | -$0.32 | Miss |
| May 1, 2025 | -$0.35 | -$0.29 | Beat |